pregnancy tests Gillette MACH3, Venus and Sensor razors and refill cartridges Lotrimin Nicorette Oil of Olay Oral B replacement heads Pepcid AC
Prilosec Primatene RoC Rogaine Similac Sudafed Schick Quattro razors and all Schick refill cartridges Sonicare replacement heads Tylenol Extra Strength Visine Zantac
For example, Pepcid AC
, once one of the hottest brands in the overall HBC market, showed a 24% decline in dollar volume last year.
Zantac 75, Tagamet 100 and Pepcid AC
are the Rolls-Royces of the indigestion world.
Axid AR joins Pepcid AC
, Tagamet HB and Zantac 75 in competition for consumer heartburn drugs.
The Consumer segment includes a broad range of products used in the Johnsons-branded baby care, skin care (the Aveeno, Clean & Clear, Johnsons Adult, Neutrogena, RoC, Lubrider, Dabao and Vendme lines), oral care (including the Listerine and Reach products), wound care (Band-Aid and Purell brands) and women's healthcare (Carefree, Stayfree and Vania-branded products) fields, as well as nutritional and over-the-counter pharmaceutical products, such as Splenda sweetener, Tylenol acetaminophen products, Sudafed cold, flue and allergy products, Zyrtec allergy products, Motrin IB ibuprofen products and Pepcid AC
Acid Controller from Johnson & Johnson Merck Consumer Pharmaceuticals Co.
The approved ANDA is bioequivalent and therapeutically equivalent to Pepcid AC
tablets (McNeil Consumer Pharmaceuticals Co.
In April 1995, Johnson & Johnson/Merck received approval from the FDA to market Pepcid AC
and subsequently launched the product the following June.
Clearly the gain in 1995 reflects the launch of Pepcid AC
in April and Tagamet HB in August.
Food and Drug Administration of Maximum Strength Pepcid AC
(famotidine) for over-the-counter usage.
And, this year, the market was forever changed by the entries of Pepcid AC
and Tagamet HB.
Put options on pharmaceutical giant Merck (NYSE:MRK) were active Friday, one day after yesterday's announcement that Johnson & Johnson-Merck Consumer Pharmaceuticals Company had received Food and Drug Administration (FDA) approval for its over-the-counter maximum strength Pepcid AC
Consider this, Johnson & Johnson, in a joint venture with Merck, invested $100 million against the media launch of Pepcid AC
, their entry into the Rx-to-OTC conversion antacid market.
Zantac from Boehringer Ingelheim, Pepcid AC
from McNeil Consumer Pharmaceuticals Co.